Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants.

Authors :: Hartnett, M. Elizabeth
Wallace, David K.
Dean, Trevano W.
Li, Zhuokai
Boente, Charline S.
Dosunmu, Eniolami O.
Freedman, Sharon F.
Golden, Richard P.
Kong, Lingkun
Prakalapakorn, S. Grace
Repka, Michael X.
Smith, Lois E.
Wang, Haibo
Kraker, Raymond T.
Cotter, Susan A.
Holmes, Jonathan M.
Writing Committee for the Pediatric Eye Disease Investigator Group
Source :: JAMA Ophthalmology; Apr2022, Vol. 140 Issue 4, p337-344, 8p
Publication Year :: 2022

Full Text Access

Tools